Fortis Healthcare : Outcome Of Board Meeting February 07, 2025

	Fortis Healthcare Limited
	Tower-A, Unitech Business Park, Block-F,
	South City 1, Sector - 41, Gurgaon,
	Haryana - 122 001 (India)
	Tel	: 0124 492 1033
	Fax	: 0124 492 1041
	Emergency	: 105010
	Email	: [e-mail]
	Website	: www.fortishealthcare.com
FHL/SEC/2024-25	February 07, 2025
The National Stock Exchange of India Ltd.	BSE Limited
Scrip Symbol: FORTIS	Scrip Code:532843

Sub: Outcome of the Board Meeting under Regulation 30 and Regulation 51(2) and 52 of Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015

Dear Madam/Sir,

Pursuant to the provisions of Regulation 30 and Regulation 51(2) and 52 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015 ("SEBI Listing Regulations") and the Master Circular issued by SEBI through circular number SEBI/HO/DDHS/DDHS-PoD- 1/P/CIR/2024/48 dated May 21, 2024 and December 31, 2024 as amended, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. February 07, 2025 have, inter-alia, considered and approved the following matters:

Financial Results

Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter and period ended on December 31, 2024 ("Quarterly Results").

Accordingly, please find enclosed herewith Un-Audited Standalone and Consolidated Financial Results of the Company along with limited review report given by the Statutory Auditors of the Company for the quarter and period ended on December 31, 2024.

Amendment in Articles of Association (AOA) of the Company

Recently, the Company has allotted 1,55,000 (One lac and fifty-five thousand) listed, senior, secured, rated, redeemable Non-Convertible Debentures each having a face value of INR 1,00,000/- (Indian Rupees One lac) and an aggregate value of up to INR 1550,00,00,000/- (Indian Rupees One Thousand Five Hundred and Fifty Crores only) ("Debentures" or "NCDs") on a private placement basis to the eligible investors.

As per Securities and Exchange Board of India (Issue and Listing of Non-Convertible Securities) (Amendment) Regulations, 2023, the Company shall ensure that Articles of Association enables its board of directors, to appoint the person nominated by the debenture trustee(s) in terms of clause (e) of sub-regulation (1) of Regulation 15 of the Securities and Exchange Board of India (Debenture Trustees) Regulations, 1993 as a director on its Board ("Nominee Director"), in the event of default in relation to Non-Convertible Debentures.

In order to make the Articles of Association of the Company comply with the above-mentioned requirements, the Articles of Association of the Company were previously amended to insert new clause 89(3) in relation to the appointment of Nominee Director. The Article 89(3) is to be further amended to elucidate the specific right of the debenture trustee in view of the recent listed non-convertible debentures and to establish an obligation of board specifically to appoint a nominee director upon nomination by a debenture trustee, in the event of default.

FORTIS HEALTHCARE LIMITED

Regd. Office : Fortis Hospital, Sector 62, Phase - VIII, Mohali - 160062 Tel : [phone], Fax : [phone], CIN : L85110PB1996PLC045933

Fortis Healthcare Limited

Tower-A, Unitech Business Park, Block-F,

South City 1, Sector - 41, Gurgaon,

Haryana - 122 001 (India)

Tel	: 0124 492 1033
Fax	: 0124 492 1041
Emergency	: 105010
Email	: [e-mail]
Website	: www.fortishealthcare.com

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') and our earlier intimation dated August 30, 2024, we hereby inform that the board of directors had considered and approved amendment of Article of Association of the Company by inserting the word "Debenture Trustee" in Article 89(3).

Amendment in Policy on Materiality of Events

The Board of Directors considered and approved the materiality policy incorporating amendments to listing regulations with regard to Regulation 30(11) of SEBI Listing Regulations.

Further, the Amended Materiality policy is annexed herewith.

The Board Meeting commenced at 1100 Hours IST and concluded at 1740 Hours IST.

This is for your information and record.

Thanking You,

Yours Sincerely,

For Fortis Healthcare Limited

Satyendra Chauhan

Company Secretary & Compliance Officer

M. No. A14783

Encl :a/a

FORTIS HEALTHCARE LIMITED

Regd. Office : Fortis Hospital, Sector 62, Phase - VIII, Mohali - 160062 Tel : [phone], Fax : [phone], CIN : L85110PB1996PLC045933